Atlas Trials

A Study to Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune Encephalitis In Children 12 Years or Older and Adults

Clinical trial NCT07583641 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07583641
Sponsor
argenx
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Autoimmune Encephalitis (AE)
Start date
2026-07-13
Primary completion
2029-01-20
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.